HOME >> MEDICINE >> NEWS
Single dose of azithromycin prevents recurrence of inturned eyelashes

A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye. The oral antibiotic treatment is more effective than multiple days of treatment with the topical antibiotic ointment Tetracycline, the current method of treatment after trichiasis surgery.

Trichiasis is the leading infectious cause of blindness worldwide. It is a condition in which the eyelid turns inward and the eyelashes rub against the eye, causing corneal scarring, that can lead to blindness. It results from years of repeated episodes of trachoma, an ocular bacterial infection that is very common in rural areas of developing countries.

The bacteria that cause trachoma are suspected to be spread by contact with hands or clothing of infected individuals. Flies may also transfer the infection from one person to another. Because trachoma is transmitted through close personal contact, it tends to occur in clusters, often infecting entire families and a large majority of people in a given community. The disease usually remains hidden in rural areas of developing countries where people live in overcrowded conditions with limited access to water and health care.

Trichiasis can be corrected by appropriate lid surgery, which returns the inturned eyelashes to their normal position. However, even under the best of circumstances the eyelashes may turn back in (between 16 percent and 50 percent within a few years after surgery). That's why this new Johns Hopkins research is so valuable, says lead researcher Sheila West, Ph.D., of the Dana Center for Preventative Ophthalmology at Johns Hopkins Medicine. In the current study, less than 10 percent of people had their eyelid turn in again within one year after surgery.

In the study, published in the March 2006 issue of the Archives of Ophthalmology, the research team found that a sing
'"/>

Contact: John M. Lazarou
Jlazaro1@jhmi.edu
410-502-8902
Johns Hopkins Medical Institutions
13-Mar-2006


Page: 1 2

Related medicine news :

1. Single-visit program for cervical cancer screening increases rate of follow-up, treatment
2. Single dose of chemotherapy is as effective as radiotherapy for testicular cancer
3. Single-dose antibiotics reduce appendectomy complications
4. Monthly interpersonal psychotherapy prevents relapse of depression in many women
5. Rare cell prevents rampant brain activity
6. What prevents doctors from counseling their patients to lose weight, exercise and quit smoking?
7. Less television and more gathering around the dinner table prevents
8. Sildenafil prevents rebound pulmonary hypertension in infants
9. Drug prevents postpartum hemorrhage in resource poor settings
10. Anti-inflammatory drug prevents liver cancer in at-risk liver patients
11. New vaccine prevents cervical cancer in teens

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2019)... ... December 06, 2019 , ... Allegheny Health Network (AHN) has named ... joined AHN from WVU Medicine in May 2018, previously served as AHN’s Vice Chair ... interim chair since October and is also part of the pathology faculty at Drexel ...
(Date:12/6/2019)... ... December 06, 2019 , ... Dr. Scott Howell, a 2019 ... published research on the health benefits of coconut oil in the 7 November 2019 ... Effects on the Cardiometabolic Profile: A Structured Literature Review,” led by Dr. Hector O. ...
(Date:12/5/2019)... ... 2019 , ... It’s been an impactful year for ... embrace, achieve, and maintain a healthy lifestyle to giving generously to communities in ... of impacting world health, so it’s gratifying to look back on the many ...
(Date:12/4/2019)... ... 2019 , ... Healthcare Real Estate Insights™ magazine has announced ... to recognizing excellence in the areas of healthcare real estate (HRE) development and ... during the GlobeSt Healthcare Conference today in Scottsdale, Ariz. , The awards are ...
(Date:12/2/2019)... ... December 02, 2019 , ... TrialScope, the global leader ... the North American branch of the healthcare business of Merck KGaA, Darmstadt, Germany, ... educate and inform patients, caregivers, the public, patient advocacy groups and healthcare professionals ...
Breaking Medicine News(10 mins):
(Date:12/5/2019)... ... December 05, 2019 , ... Cognosante is ... Sector Partner Program; a designation that will accelerate digital transformation for public ... partners that offer solutions and proven experience delivering on government, education and ...
(Date:12/4/2019)... , ... December 04, 2019 , ... ... healthcare professionals with minimally invasive technologies to treat chronic pain in soft and ... the Tenex Health TX® technology. , Dr. Bernard Morrey, Chief Medical ...
(Date:12/2/2019)... ... December 02, 2019 , ... Data integration has been a pharma industry buzzword ... and external data sources, staff are still working in silos and are not aware ... take six weeks or more, and nearly one-third of qualified investigators may be overlooked. ...
Breaking Medicine Technology:
Cached News: